Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Multiple Sclerosis Brain Lesion”

30 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 30 results

Not applicableEnded earlyNCT02967380
What this trial is testing

Gadobutrol Versus Gadopentetate Dimeglumine or Gadobenate Dimeglumine Before DCE-MRI in Diagnosing Patients With Multiple Sclerosis, Grade II-IV Glioma, or Brain Metastases

Who this might be right for
Adult Anaplastic (Malignant) MeningiomaAdult Anaplastic AstrocytomaAdult Anaplastic Ependymoma+22 more
University of Southern California 14
Not applicableStudy completedNCT00094068
What this trial is testing

The Effect of Sildenafil Citrate (Viagra® (Registered Trademark)) on Brain Blood Flow in Multiple Sclerosis Patients

Who this might be right for
Multiple Sclerosis
National Institutes of Health Clinical Center (CC) 76
Not applicableStudy completedNCT00617383
What this trial is testing

AT RISK FOR MS - Clinical Conversion of Female Monozygotic Twins Discordant for CIS/MS

Who this might be right for
Multiple SclerosisClinically Isolated Syndrome
The University of Texas Health Science Center, Houston 3
Testing effectiveness (Phase 2)Study completedNCT00879658
What this trial is testing

Safety, Tolerability, Efficacy and Optimal Dose Finding Study of BAF312 in Patients With Relapsing-remitting Multiple Sclerosis

Who this might be right for
Relapsing-remitting Multiple Sclerosis
Novartis Pharmaceuticals 297
Not applicableStudy completedNCT05426980
What this trial is testing

Artificial Intelligence in Predicting Progression in Multiple Sclerosis Study

Who this might be right for
Multiple SclerosisMultiple Sclerosis LesionMultiple Sclerosis Brain Lesion
University of Ljubljana 654
Not applicableEnded earlyNCT01836055
What this trial is testing

Imaging Multiple Sclerosis Lesions Using Magnevist and Gadavist

Who this might be right for
Multiple Sclerosis
Wayne State University 19
Not applicableWithdrawnNCT04344626
What this trial is testing

Use of a Tonometer to Identify Epileptogenic Lesions During Pediatric Epilepsy Surgery

Who this might be right for
EpilepsyFocal Cortical DysplasiaTuberous Sclerosis+7 more
University of California, Los Angeles
Large-scale testing (Phase 3)Study completedNCT03315923
What this trial is testing

Comparison of Clinical Effects of Rituximab and Glatiramer Acetate in Secondary Progressive Multiple Sclerosis Patients

Who this might be right for
Secondary Progressive Multiple Sclerosis
Isfahan University of Medical Sciences 84
Not applicableStudy completedNCT03438357
What this trial is testing

Evaluation of an Automatic Segmentation Software (Pixyl.Neuro) to Track Lesions in Multiple Sclerosis Patients Via Cerebral MRI

Who this might be right for
Multiple SclerosisClinically Isolated Syndrome
Centre Hospitalier Universitaire de Nīmes 200
Not applicableEnded earlyNCT03660618
What this trial is testing

LSFG-SKIN, Laser Speckle Flowgraphy

Who this might be right for
HypertensionHeart FailureVascular Ischemia+13 more
Randy Kardon 1
Testing effectiveness (Phase 2)Study completedNCT00676715
What this trial is testing

The Efficacy and Safety of Ocrelizumab in Patients With Relapsing-Remitting Multiple Sclerosis

Who this might be right for
Multiple Sclerosis, Relapsing-Remitting
Genentech, Inc. 220
Not applicableStudy completedNCT05718947
What this trial is testing

Ultra-high-field Brain MRI in Multiple Sclerosis

Who this might be right for
Multiple Sclerosis
Zuyderland Medisch Centrum 10
Testing effectiveness (Phase 2)UnknownNCT03356769
What this trial is testing

Aspirin as an add-on Treatment of Refractory Epilepsy in Tuberous Sclerosis Complex

Who this might be right for
Tuberous Sclerosis ComplexAspirinEpilepsy+2 more
Peking Union Medical College Hospital 98
Not applicableLooking for participantsNCT07444047
What this trial is testing

MRI-Based Lesion Differentiation in Older Patients With Multiple Sclerosis

Who this might be right for
Multiple Sclerosis (MS)Cerebral Small Vessel Diseases
Oslo University Hospital 1,000
Post-approval studies (Phase 4)WithdrawnNCT00037115
What this trial is testing

Induction Therapy With a Single High Dose Bolus of Intravenous Methotrexate With Leucovorin Rescue, Prior to Initiation of AVONEX® Treatment, in Patients Presenting With a First Acute Demyelinating Event.

Who this might be right for
Demyelinating DisordersMultiple SclerosisOptic Neuritis+2 more
MidAmerica Neuroscience Research Foundation at Rowe Neurology Institute
Testing effectiveness (Phase 2)Looking for participantsNCT05359653
What this trial is testing

Assessing Changes in Multi-parametric MRI in MS Patients Taking Clemastine Fumarate as a Myelin Repair Therapy

Who this might be right for
Multiple Sclerosis (MS)Multiple Sclerosis, Relapsing-RemittingMultiple Sclerosis, Primary Progressive+4 more
University of California, San Francisco 74
Not applicableStudy completedNCT00099307
What this trial is testing

Magnetic Resonance Imaging to Detect Brain Damage in Patients With Multiple Sclerosis

Who this might be right for
Multiple Sclerosis
National Institute of Neurological Disorders and Stroke (NINDS) 94
Not applicableStudy completedNCT04123353
What this trial is testing

Scan-Rescan Sub-Study of MS PATHS

Who this might be right for
Multiple Sclerosis
Biogen 30
Not applicableLooking for participantsNCT06955832
What this trial is testing

Early Identification of Brain Lesions in Multiple Sclerosis With Phase Sensitive Inversion Recovery MRI

Who this might be right for
Multiple Sclerosis
Benha University 30
Testing effectiveness (Phase 2)Study completedNCT06322342
What this trial is testing

Phase 2 Ascending Dose Safety and Efficacy Study of RVP-001, a Manganese-based MRI Contrast Agent

Who this might be right for
Central Nervous System (CNS) LesionsBrain MetastasesBrain Neoplasms+22 more
Reveal Pharmaceuticals Inc. 18
Load More Results